09 Jun 2020 --- Technology enterprise Zeiss has partnered with newly established venture Perseus Biomics to develop an optical technology to further research of the microbiome. The partnership aims to leverage and develop Perseus’s “MAP” platform for quantitative analysis toward this purpose. This technology is regarded as delivering a quick and cost-effective way to characterize the microbiome. By means of quantitative analysis, the partnership aims to unlock the full potential of research toward personalized medicine. The terms of the deal have not been disclosed.
